Cargando…
Familial aggregation of longevity in giant cell arteritis and polymyalgia rheumatica
The long-term mortality in giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) is unexpectedly decreased or at least not increased regardless of several mortality risk factors that these diseases share with other chronic immune-mediated rheumatic diseases. The genetic and immunological profi...
Autores principales: | Milchert, Marcin, Brzosko, Marek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591435/ https://www.ncbi.nlm.nih.gov/pubmed/32683496 http://dx.doi.org/10.1007/s00296-020-04649-7 |
Ejemplares similares
-
Diagnosis of polymyalgia rheumatica usually means a favourable outcome for your patient
por: Milchert, Marcin, et al.
Publicado: (2017) -
Is Tocilizumab Effective and Safe in Polymyalgia Rheumatica and Giant-Cell Arteritis With Polymyalgia Rheumatica?
por: Farinango, Michelle, et al.
Publicado: (2022) -
Antimitochondrial Antibodies and Primary Biliary Cholangitis in Patients with Polymyalgia Rheumatica/Giant Cell Arteritis
por: Manzo, Ciro, et al.
Publicado: (2021) -
Liver involvement in polymyalgia rheumatica and giant cell arteritis
por: Hysa, Elvis, et al.
Publicado: (2020) -
Optimal management of giant cell arteritis and polymyalgia rheumatica
por: Charlton, Rodger
Publicado: (2012)